Patents by Inventor Michael Joannidis

Michael Joannidis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant alkaline phosphatase for use in treating sepsis-associated acute kidney injury
    Patent number: 12178857
    Abstract: The present disclosure relates to the use of alkaline phosphatases, and in particular improved alkaline phosphatases such as RecAP, for the prevention, treatment, cure, or amelioration of the symptoms of acute kidney injury caused, e.g., by sepsis. The application relates to methods of preserving renal function renal function, shortening the duration of renal replacement therapy, increasing the creatinine clearance, decreasing the risk of death in subjects with sepsis-associate acute kidney injury (SA-AKI) or at risk of SA-AKI.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: December 31, 2024
    Assignee: AM-Pharma B.V.
    Inventors: Roelof Peter Pickkers, Ravindra Lall Mehta, Patrick Thomas Murray, Michael Joannidis, Erik Jan Van Den Berg, Jacques Salomon Robert Arend